CAN
Claraphi Advisory Network’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $503K | Buy |
3,112
+1,621
| +109% | +$262K | 0.2% | 132 |
|
|
2022
Q3 | $200K | Sell |
1,491
-18,086
| -92% | -$2.43M | 0.11% | 181 |
|
|
2022
Q2 | $3M | Buy |
19,577
+1,766
| +10% | +$270K | 1.05% | 13 |
|
|
2022
Q1 | $2.89M | Buy |
17,811
+8,016
| +82% | +$1.3M | 0.83% | 23 |
|
|
2021
Q4 | $1.33M | Sell |
9,795
-718
| -7% | -$97.2K | 0.46% | 48 |
|
|
2021
Q3 | $1.13M | Sell |
10,513
-410
| -4% | -$44.2K | 0.4% | 51 |
|
|
2021
Q2 | $1.23M | Sell |
10,923
-649
| -6% | -$73.1K | 0.37% | 50 |
|
|
2021
Q1 | $1.25M | Buy |
11,572
+432
| +4% | +$46.7K | 0.35% | 59 |
|
|
2020
Q4 | $1.19M | Sell |
11,140
-2,162
| -16% | -$232K | 0.33% | 56 |
|
|
2020
Q3 | $1.17M | Sell |
13,302
-3,344
| -20% | -$293K | 0.42% | 40 |
|
|
2020
Q2 | $1.63M | Buy |
16,646
+5,175
| +45% | +$508K | 0.7% | 29 |
|
|
2020
Q1 | $874K | Buy |
11,471
+933
| +9% | +$71.1K | 0.41% | 39 |
|
|
2019
Q4 | $933K | Sell |
10,538
-337
| -3% | -$29.8K | 0.57% | 35 |
|
|
2019
Q3 | $823K | Sell |
10,875
-250
| -2% | -$18.9K | 0.5% | 41 |
|
|
2019
Q2 | $809K | Buy |
11,125
+1,263
| +13% | +$91.8K | 0.47% | 45 |
|
|
2019
Q1 | $795K | Buy |
9,862
+1,318
| +15% | +$106K | 0.5% | 42 |
|
|
2018
Q4 | $787K | Buy |
8,544
+607
| +8% | +$55.9K | 0.6% | 40 |
|
|
2018
Q3 | $751K | Buy |
7,937
+3,674
| +86% | +$348K | 0.42% | 57 |
|
|
2018
Q2 | $395K | Sell |
4,263
-86
| -2% | -$7.97K | 0.25% | 105 |
|
|
2018
Q1 | $411K | Buy |
4,349
+716
| +20% | +$67.7K | 0.29% | 101 |
|
|
2017
Q4 | $351K | Buy |
+3,633
| New | +$351K | 0.27% | 108 |
|